{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:10:13Z","timestamp":1782990613567,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.bbrc.2008.01.103","type":"journal-article","created":{"date-parts":[[2008,2,2]],"date-time":"2008-02-02T12:18:58Z","timestamp":1201954738000},"page":"414-418","source":"Crossref","is-referenced-by-count":14,"title":["Prevention and promotion effects of apolipoprotein E4 on amylin aggregation"],"prefix":"10.1016","volume":"368","author":[{"given":"Peng","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-wang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-wen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-fen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2008.01.103_bib1","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.01.103_bib2","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.01.103_bib3","first-page":"47","article-title":"Amyloid and polypeptide hormones\u2014what is their interrelationship","volume":"1","author":"Westermark","year":"1994","journal-title":"Amyloid Int. J. Exp. Clin. Invest."},{"key":"10.1016\/j.bbrc.2008.01.103_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00403322","article-title":"Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians","volume":"33","author":"Clark","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2008.01.103_bib5","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.2337\/diabetes.48.10.1962","article-title":"Two novel immortal pancreatic beta-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid","volume":"48","author":"Andrikopoulos","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2008.01.103_bib6","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI29103","article-title":"Islet beta cell failure in type 2 diabetes","volume":"116","author":"Prentki","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2008.01.103_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2008.01.103_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","article-title":"Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid","volume":"135","author":"Wisniewski","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2008.01.103_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/(SICI)1096-9896(199608)179:4<443::AID-PATH612>3.0.CO;2-7","article-title":"Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer\u2019s disease","volume":"179","author":"Charge","year":"1996","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbrc.2008.01.103_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0022-510X(96)00123-2","article-title":"Effect of cerebrospinal fluid from normal and Alzheimer\u2019s patients with different apolipoprotein E phenotypes on in vitro aggregation of amyloid beta-protein","volume":"141","author":"Chauhan","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbrc.2008.01.103_bib11","doi-asserted-by":"crossref","first-page":"15598","DOI":"10.1073\/pnas.95.26.15598","article-title":"Opposite roles of apolipoprotein E in normal brains and in Alzheimer\u2019s disease","volume":"95","author":"Russo","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.01.103_bib12","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","article-title":"Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model","volume":"25","author":"Fryer","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2008.01.103_bib13","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.01.103_bib14","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.01.103_bib15","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1074\/jbc.271.18.10602","article-title":"The interaction between apolipoprotein E and Alzheimer\u2019s amyloid beta-peptide is dependent on beta-peptide conformation","volume":"271","author":"Golabek","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2008.01.103_bib16","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2008.01.103_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2008.01.103_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrc.2008.01.103_bib19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9440(10)63355-X","article-title":"A synthetic peptide blocking the apolipoprotein E\/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice","volume":"165","author":"Sadowski","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2008.01.103_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-5793(95)01512-4","article-title":"Effects of beta cell granule components on human islet amyloid polypeptide fibril formation","volume":"379","author":"Westermark","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2008.01.103_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jmb.2003.10.045","article-title":"The mechanism of insulin action on islet amyloid polypeptide fiber formation","volume":"335","author":"Larson","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2008.01.103_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.92.3.763","article-title":"Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease","volume":"92","author":"Evans","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.01.103_bib23","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1074-5521(96)90183-0","article-title":"An ApoE\u2013Abeta inhibition complex in Abeta fibril extension","volume":"3","author":"Wood","year":"1996","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbrc.2008.01.103_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0531-5565(03)00004-4","article-title":"Islet amyloid polypeptide and type 2 diabetes","volume":"38","author":"Marzban","year":"2003","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbrc.2008.01.103_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00125-002-0984-5","article-title":"The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice","volume":"46","author":"Vidal","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2008.01.103_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-8227(02)00281-4","article-title":"Apolipoprotein E genotype, islet amyloid deposition and severity of Type 2 diabetes","volume":"60","author":"Powell","year":"2003","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrc.2008.01.103_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343","author":"Hoppener","year":"2000","journal-title":"N. Engl. J. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X0800168X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X0800168X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T17:01:48Z","timestamp":1557248508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X0800168X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0006291X0800168X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2008.01.103","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}